Perioperative Management of Type 2N Von Willebrand’s Disease with Recombinant Factor VIII in a Patient Undergoing Knee-Replacement Surgery
Type 2N Von Willebrand's disease (2N VWD) is a rare, recessively inherited bleeding disorder, comprising 1-2% of all VWD patients, usually manifesting as a mild bleeding diathesis. Treatment includes desmopressin (DDAVP) or intermediate purity plasma-derived FVIII concentrates containing residu...
Main Authors: | Srivasavi Dukka, David John Allsup |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/837906 |
Similar Items
-
Total knee arthroplasty in a patient with severe von Willebrand disease (Perioperative treatment of von Willebrand disease)
by: Bralušić Lazar, et al.
Published: (2018-01-01) -
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
by: Prashant Sharma
Published: (2019-01-01) -
Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
by: Hiroyuki Oshika, et al.
Published: (2019-08-01) -
Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome
by: Ritsuko Sasaki, et al.
Published: (2018-09-01) -
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)